Balance Labs, Inc. Financial Summary

Quick Answer

Balance Labs, Inc. reported Total Revenue of $247.5 thousand for fiscal year 2022.

Balance Labs, Inc. — Key Financials by Year

Metric 2024 2023 2022 2021 2020 2019
Total Revenue $247.5K
-60.4%
$624.6K
-37.5%
$1.00M
+29903.0%
$3.3K
-50.0%
Revenue (ASC 606) $247.5K
-60.4%
$624.6K
-37.5%
$1.00M
+29903.0%
$3.3K
-50.0%
Net Income -$528.2K
-38.4%
-$381.6K
+50.3%
-$768.4K
+3.6%
-$796.7K
-322.7%
$357.8K
+140.5%
-$884.2K
-61.4%
Diluted EPS -$0.02
+0.0%
-$0.02
-150.0%
$0.04
+0.0%
$0.04
+100.0%
$0.02
+150.0%
-$0.04
Total Assets $95.6K
-56.7%
$220.7K
-48.6%
$429.1K
-57.7%
$1.01M
-20.1%
$1.27M
+435.1%
$237.4K
-24.6%
Cash and Equivalents $13.2K
-88.3%
$112.8K
-52.1%
$235.3K
+3.4%
$227.6K
+3940.4%
$5.6K
-38.7%
$9.2K
-66.3%
Stockholders Equity -$5.07M
-11.6%
-$4.54M
-9.2%
-$4.16M
-22.6%
-$3.39M
-33.9%
-$2.53M
+12.4%
-$2.89M
-39.5%
Operating Income -$271.3K
-133.3%
-$116.3K
-409.3%
-$22.8K
-110.2%
$224.4K
-63.4%
$612.5K
+209.8%
-$557.9K
+7.5%
Shares Outstanding 21.67M
+0.0%
21.67M
+0.0%
21.67M
+0.0%
21.67M
+0.0%
21.67M
+0.0%
21.67M
+0.2%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2022 $67.5K -66.2% +0.0%
Revenue (ASC 606) September 30, 2022 $67.5K -66.2% +0.0%
Net Income March 31, 2025 -$6.4K +94.5% +96.7%
Diluted EPS September 30, 2025 -$0.16 -1500.0% -1500.0%
Total Assets September 30, 2025 $53.1K -51.8% -31.2%
Cash and Equivalents September 30, 2025 $4.5K -85.2% +24.5%
Stockholders Equity September 30, 2025 -$8.68M -75.1% -66.1%
Operating Income September 30, 2025 -$211.1K -152.3% -166.4%
Shares Outstanding September 30, 2025 22.45M +3.6% +3.6%
  • Balance Labs, Inc. reported Total Revenue of $247.5 thousand for fiscal year 2022.
  • Balance Labs, Inc. showed a decrease of -60.4% in Total Revenue compared to the prior fiscal year.
  • Balance Labs, Inc. reported Revenue (ASC 606) of $247.5 thousand for fiscal year 2022.
  • Balance Labs, Inc. showed a decrease of -60.4% in Revenue (ASC 606) compared to the prior fiscal year.
  • Balance Labs, Inc. reported Net Income of -$528.2 thousand for fiscal year 2024.
  • Balance Labs, Inc. showed a decrease of -38.4% in Net Income compared to the prior fiscal year.
  • Balance Labs, Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2024.
  • Balance Labs, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
  • Balance Labs, Inc. reported Total Assets of $95.6 thousand for fiscal year 2024.
  • Balance Labs, Inc. showed a decrease of -56.7% in Total Assets compared to the prior fiscal year.
  • Balance Labs, Inc. reported Cash and Equivalents of $13.2 thousand for fiscal year 2024.
  • Balance Labs, Inc. showed a decrease of -88.3% in Cash and Equivalents compared to the prior fiscal year.
  • Balance Labs, Inc. reported Stockholders Equity of -$5.07 million for fiscal year 2024.
  • Balance Labs, Inc. showed a decrease of -11.6% in Stockholders Equity compared to the prior fiscal year.
  • Balance Labs, Inc. reported Operating Income of -$271.3 thousand for fiscal year 2024.
  • Balance Labs, Inc. showed a decrease of -133.3% in Operating Income compared to the prior fiscal year.
  • Balance Labs, Inc. reported Shares Outstanding of 21.67 million shares for fiscal year 2024.
  • Balance Labs, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment